Warner Chilcott

Rockaway, United States Founded: 1999 • Age: 27 yrs Acquired By Actavis
Contract research, development, and manufacturing for biologic drugs are offered.

About Warner Chilcott

Warner Chilcott is a Healthcare company based in Rockaway (United States) founded in 1999, and was acquired by Actavis in May 2013. Contract research, development, and manufacturing for biologic drugs are offered. Its chief executive, as recorded, is Rodger Boissonneault. Its focus areas include Biopharma Outsourcing, Diversified and Biologics. Its competitors include Catalent, Surrozen and Curia; 1 of its 3 listed competitors has raised funding.

Company details

Warner Chilcott was founded in 1999 and is headquartered in Rockaway, United States. Services in contract research, development, and manufacturing are provided for biologic drugs within the pharmaceutical sector. Operations focus on supporting clients through end-to-end processes for biologic products, with emphasis on regulatory compliance and quality standards in the biotechnology industry.

  • Headquarters Rockaway, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website wcrx.com
  • Social LinkedIn
  • Acquired by Actavis (May 2013)
Key Metrics

Investors in Warner Chilcott

Warner Chilcott has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Bain Capital Private Equity, Actavis and Thomas H Lee Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private investment firm managing assets and expanding into equity, credit, and real estate services.
1984baincapitalprivateequity.comLondon, United Kingdom
Private equity investments are directed toward traditional industries.
1974thl.comBoston, United States
Private equity investments are directed toward multiple sectors.
ccmpcapital.comNew York, United States
Manufacturer of generic products
1956actavis.comParsippany Troy Hills, United States
Premium access

Investor details for Warner Chilcott

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Warner Chilcott

1 people are tracked at Warner Chilcott (1 in leadership).

NameRoleGroup
Rodger Boissonneault
CEOLeadership
Premium access

Complete people profiles for Warner Chilcott

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Warner Chilcott

3 dated milestones of Warner Chilcott across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Warner Chilcott is founded.
  2. Exit Acquired by CCMP Capital.
  3. Exit Acquired by Actavis.

Competitors of Warner Chilcott

Warner Chilcott has 3 listed competitors in our database, 1 of them funded. They include Catalent, Surrozen and Curia.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
catalent.com2007Somerset, United States9,390
CDMO offering drug and biologics development services
surrozen.com2016San Francisco, United States$133M80
Selective Wnt agonists are developed for human tissue regeneration.
curiaglobal.com1991Albany, United States1,918
Drug research, development, testing, and consulting services are provided.
Premium access

Detailed competitors of Warner Chilcott

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Warner Chilcott (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Warner Chilcott

Premium access

Complete news archive for Warner Chilcott

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Warner Chilcott

Warner Chilcott was founded in 1999.

Warner Chilcott is headquartered in Rockaway, United States. It is registered at Rockaway, New Jersey, United States.

Rodger Boissonneault is the CEO of Warner Chilcott, as recorded in our data.

Warner Chilcott was founded in 1999 and is headquartered in Rockaway, United States. Services in contract research, development, and manufacturing are provided for biologic drugs within the pharmaceutical sector. Operations focus on supporting clients through end-to-end processes for biologic products, with emphasis on regulatory compliance and quality standards in the biotechnology industry.

Warner Chilcott's top competitors include Surrozen, Catalent and Curia.

Warner Chilcott has 4 investors. Key investors include Bain Capital Private Equity, Actavis, Thomas H Lee Partners, and CCMP Capital.

Yes. Warner Chilcott was acquired by Actavis in May 2013.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available